The Novartis AG (NVS) ROIC is 17.7%, compared to the industry median of (13.5%) and the 5-year historical average of 11.3%.
The Novartis AG (NVS) ROIC minus WACC is 10.8%, compared to the industry median of (6.1%) and the 5-year historical average of 6.0%.
The Novartis AG (NVS) ROE is 27.3%, compared to the industry median of (20.0%) and the 5-year historical average of 21.5%.
The Novartis AG (NVS) ROCE is 17.5%, compared to the industry median of (11.6%) and the 5-year historical average of 11.0%.